Covered recipient · General Payments record
VENEAH HALL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2021
$297.96
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $297.96 | 15 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $49.73 | 3 |
| Exeltis, USA Inc. | $37.80 | 2 |
| Ethicon US, LLC | $35.96 | 1 |
| PFIZER INC. | $33.75 | 2 |
| Axonics Modulation Technologies, Inc. | $32.25 | 1 |
| Astellas Pharma US Inc | $23.00 | 1 |
| Daiichi Sankyo Inc. | $22.86 | 1 |
| Biohaven Pharmaceuticals, Inc. | $21.53 | 1 |
| Mylan Pharmaceuticals Inc. | $16.74 | 1 |
| Avion Pharmaceuticals | $12.48 | 1 |
| TherapeuticsMD, Inc. | $11.86 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $297.96 | 15 |
Payment records · PY2021 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $16.56 | 06/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794422425 | CMS |
| AbbVie Inc. | $14.96 | 10/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794422429 | CMS |
| AbbVie Inc. | $18.21 | 11/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794422433 | CMS |
| Astellas Pharma US Inc | $23.00 | 05/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 821687935 | CMS |
| Avion Pharmaceuticals | $12.48 | 02/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 845430927 | CMS |
| Axonics, Inc. | $32.25 | 11/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 840588277 | CMS |
| Biohaven Pharmaceuticals, Inc. | $21.53 | 07/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 852737557 | CMS |
| Daiichi Sankyo Inc. | $22.86 | 08/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836321949 | CMS |
| Ethicon US, LLC | $35.96 | 09/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 787533399 | CMS |
| Exeltis, USA Inc. | $20.99 | 09/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 806184471 | CMS |
| Exeltis, USA Inc. | $16.81 | 10/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 806177293 | CMS |
| Mylan Pharmaceuticals Inc. | $16.74 | 07/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 965464051 | CMS |
| PFIZER INC. | $19.26 | 06/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 833312755 | CMS |
| PFIZER INC. | $14.49 | 08/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 833367439 | CMS |
| TherapeuticsMD, Inc. | $11.86 | 11/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 844983225 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.